Article Text

Download PDFPDF
Targeting the use of ovarian cyst aspirate cytology
  1. H Monaghan,
  2. A Al-Nafussi
  1. Department of Laboratory Medicine (Pathology), Royal Infirmary of Edinburgh, 51 Little France Crescent, Little France, Edinburgh EH16 4SA, UK; Hannah.monaghan@luht.scot.nhs.uk

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In January 2001, the Royal College of Pathologists’ bulletin published an article entitled “A recovery plan for histopathology”.1 Following this, the Royal College of Pathologists released the document “Histopathology of limited or no clinical value”.2 This document described specific areas in histopathology where the restriction of services would not deleteriously affect patient management and would increase the time available for other cases. We identified ovarian cyst aspirates as another specimen that does not appear to have clinical importance. We describe our partly successful attempts to decrease the number of specimens received in this department.

    The risk of malignancy index (RMI) has been in clinical practice since 1990. The application of the RMI in …

    View Full Text